Maryland State Retirement & Pension System’s Cytokinetics CYTK Stock Holding History

Maryland State Retirement & Pension System’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-35,637	Closed	-$2.98M	–	1543
2023 Q4	$2.98M	Buy	35,637 +278	+0.8%	+$10.1K	0.06%	273
2023 Q3	$1.04M	Sell	35,359 -1,903	-5%	-$63.4K	0.02%	575
2023 Q2	$1.22M	Sell	37,262 -846	-2%	-$31.3K	0.03%	535
2023 Q1	$1.34M	Sell	38,108 -814	-2%	-$33.2K	0.03%	466
2022 Q4	$1.78M	Buy	38,922 +424	+1%	+$18.2K	0.05%	329
2022 Q3	$1.86M	Buy	38,498 +3,790	+11%	+$182K	0.15%	111
2022 Q2	$1.36M	Buy	34,708 +1,071	+3%	+$43.1K	0.04%	379
2022 Q1	$1.24M	Buy	33,637 +196	+0.6%	+$6.96K	0.03%	505
2021 Q4	$1.52M	Buy	33,441 +941	+3%	+$36.3K	0.04%	431
2021 Q3	$1.12M	Buy	+32,500	New	+$957K	0.03%	546

Other funds holding CYTK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Maryland State Retirement & Pension System's CYTK Position: Q1 2024 in Review

Maryland State Retirement & Pension System sold out of Cytokinetics (CYTK) in Q1 2024, closing a stake of 35,637 shares — an estimated $2.98M sold.

Maryland State Retirement & Pension System first reported a position in CYTK in Q3 2021 and held it in 10 quarters. The position peaked at $2.98M in Q4 2023. 390 funds tracked by Wall St. Rank hold CYTK as of Q1 2024.

Maryland State Retirement & Pension System reported no remaining Cytokinetics position as of Q1 2024 after selling out during the quarter.
Maryland State Retirement & Pension System sold 35,637 Cytokinetics shares in Q1 2024, an estimated $2.98M.
Maryland State Retirement & Pension System first reported a position in Cytokinetics in Q3 2021 and held it in 10 quarters.
Maryland State Retirement & Pension System's Cytokinetics position peaked at $2.98M in Q4 2023.
390 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2024.

Based on Maryland State Retirement & Pension System's 13F filing for Q1 2024, filed 19 Apr 2024.